How advances in machine learning drive early detection and risk prediction of early-onset colorectal cancer. [PDF]
Murthy SS, Schuh A.
europepmc +1 more source
Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum
This review provides a comprehensive overview of the latest advancements in the clinical utility of liquid biopsy, with a particular focus on epigenetic approaches aimed at overcoming challenges in cancer diagnosis and treatment. It begins by elucidating
Chiang-Ching Huang +3 more
core +1 more source
fRagmentomics: an R package for integrating cell-free DNA fragment features with mutational status to support liquid biopsy interpretation. [PDF]
Maudet K +3 more
europepmc +1 more source
Sinteza nove piridinijeve soli s triazolilidenskim fragmentom
This thesis describes the synthesis of a novel pyridinium salt bearing triazolylidene fragment bounded to pyridine nitrogen atom, which has not yet been described in the literature. The synthesized salt represents a potential bidentate dicarbene NHC ligand, useful for the formation of transition metal NHC complexes.
openaire +1 more source
Early multi-cancer detection using liquid biopsy: emerging biomarkers and clinical strategies. [PDF]
Nirob SR +6 more
europepmc +1 more source
From concept to clinic: emerging paradigms and novel insights into liquid biopsy. [PDF]
Guo W +7 more
europepmc +1 more source
Emerging Role of ctDNA Fragmentomics and Epigenetic Signatures in the Early Detection, Minimal Residual Disease Assessment, and Precision Monitoring of Renal Cell Carcinoma. [PDF]
Kamli H, Khan NU.
europepmc +1 more source
Circulating cell-free mtDNA fragmentomics for early detection of gastric cancer and precancerous lesions. [PDF]
Dang M +17 more
europepmc +1 more source
A machine learning framework combining cfDNA fragmentomics and serum biomarkers for early ovarian cancer detection. [PDF]
Weng W +14 more
europepmc +1 more source
Liquid biopsy, multi-cancer early detection, and artificial intelligence: new frontiers in cancer screening from a technological and immunological perspective. [PDF]
Wu D +8 more
europepmc +1 more source

